Health
Pfizer to submit emergence use approval request for Covid-19 vaccine again: Spokesperson – Deccan Herald
After reports of Pfizer withdrawing its application for emergency use authorisation of its Covid-19 vaccine in India, the company spokesperson said that it will resubmit…
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
Unlike other companies conducting small studies in India for…
-
Business14 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
General9 hours agoCan the world be governed without the US? • Inside Story
-
General22 hours agoMourners arrive for Diogo Jota’s wake in Liverpool forward’s hometown in Portugal
-
Business22 hours ago3 ASX growth shares to buy before the next bull market